SGLT2 inhibitor or metformin as standard treatment in early-stage type 2 diabetes? Baseline data in SMARTEST, a novel, decentralised, register-based randomised trial on prevention of diabetic complications
Eriksson JW, Fanni G, Lundqvist MH, et al.
Diabetes Obes Metab. Pub. online 28 Nov 2025.
Leggi


